Showing results (1-10 of 734) with videos related to

Sort By:
Pageof 74
Drug Design, Development and Therapy|May 12, 2015
Critical appraisal of bevacizumab in the treatment of ovarian cancerHiroyuki Yoshida, Akira Yabuno, Keiichi Fujiwara
Molecular and Clinical Oncology|April 29, 2016
Combination chemotherapy with docetaxel and carboplatin for elderly patients with endometrial cancerHiroyuki Yoshida, Yuichi Imai, Keiichi Fujiwara
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021
Obesity is a predictive biomarker of poor benefit from single-agent bevacizumab therapy in recurrent ovarian cancer patientsHiroyuki Yoshida, Daisuke Shintani, Keiichi Fujiwara
In Vivo (Athens, Greece)|May 2, 2020
Tolerability and Efficacy of Bevacizumab Monotherapy in Older Patients With Recurrent Ovarian CancerDaisuke Shintani, Hiroyuki Yoshida, Akira Yabuno, et al.
Archives of Gynecology and Obstetrics|August 14, 2017
Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancerHiroyuki Yoshida, Daisuke Shintani, Aiko Ogasawara, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 12, 2020
Predicting toxicity of platinum and taxane-based chemotherapy in older patients with gynecologic cancerHiroyuki Yoshida, Daisuke Shintani, Naoyuki Kawashima, et al.
Anticancer Research|October 2, 2019
MLH1 Is a Prognostic Biomarker for Serous Ovarian Cancer Treated With Platinum- and Taxane-based ChemotherapyNaoyuki Kawashima, Hiroyuki Yoshida, Maiko Miwa, et al.
Scientific Reports|October 31, 2025
RECQL1 as a potential therapeutic target for PARP inhibitor-resistant ovarian cancerHiroyuki Yoshida, Jiarui Li, Hiroaki Inui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 10, 2023
[Gynecologic Oncology Global Clinical Trial Initiatives, since 1997]Keiichi Fujiwara
Pageof 74